Please Wait.....
Report
Europe Heart Valve Devices Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 300 Pages I EMR Inc.
The Europe heart valve devices market was valued at USD 3.69 Billion in 2024, driven by the rising prevalence of cardiovascular diseases and increased funding for minimally invasive valve therapies across the region. The market is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034, with the values likely to reach USD 9.14 Billion by 2034. Technological advancements in transcatheter valve replacement and repair systems, are improving outcomes and expanding the eligible patient pool. Moreover, increased clinical adoption of TAVI (transcatheter aortic valve implantation), particularly for high-risk and inoperable patients are aiding growth in the market value.
Europe Heart Valve Devices Market Overview
Heart valve devices are medical implants designed to repair or replace damaged heart valves, ensuring proper blood flow direction and preventing complications such as valve stenosis or regurgitation. The market for heart valve devices in Europe is expanding due to the rising prevalence of cardiovascular diseases, an increasing aging population, advancements in transcatheter technologies, and growing preference for minimally invasive surgical procedures. It is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034.
Europe Heart Valve Devices Market Growth Drivers
Rising Cardiovascular Disease Burden to Drive the Market Expansion
The increasing prevalence of cardiovascular disease (CVD) remains a key growth driver in the heart valve devices market in Europe. As reported by the World Heart Federation, CVD is the leading cause of death in the European Union, impacting over 60 million people and resulting in more than 1.7 million deaths annually. This rising prevalence continues to propel demand for advanced heart valve interventions, supporting sustained market growth across the region.
Europe Heart Valve Devices Market Trends
Some of the notable trends include rising funding for minimally invasive therapies:
Increased Funding for Minimally Invasive Valve Therapies is Likely to Boost Market Growth
A notable trend in the European market for heart valve devices is the surge in investments, supporting innovative valve treatment technologies. For instance, in August 2024, CroiValve, a European Institute of Innovation and Technology-backed medtech start-up, raised USD 16 million in Series B funding to advance its heart valve treatment technology, DUO for treating tricuspid regurgitation. This funding momentum is expected to accelerate market growth and technological advancement.
Europe Heart Valve Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Valve Type
- Biological (Tissue) Valve
- Mechanical Valve
Market Breakup by Product Type
- Replacement Devices
??- Mechanical Valve
??- Bioprosthetic Valve
??- Transcatheter Aortic Valve Replacement (TAVR)
- Repair Devices
??- Surgical Valve
??- Transcatheter Mitral Valve Replacement (TMVR)
??- Balloon Valvuloplasty Devices
Market Breakup by Procedure
- Open Surgery
- Minimally Invasive Surgery (MIS)
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Market Breakup by Region
- United Kingdom
- Germany
- France
- Italy
- Others
Europe Heart Valve Devices Market Share
Biological Valves are Expected to Lead the Valve Type Segment
Based on valve types, the market is divided into biological (tissue) valves and mechanical valves. Biological valves will likely to dominate the segment due to their enhanced safety profile, reduced need for lifelong anticoagulation, and growing adoption among elderly patients. Together, these factors are driving the increasing preference for tissue-based valves across surgical and transcatheter procedures.
Segmentation by Product Type to Witness Growth in the Market
Based on the product type, the market is segmented into replacement devices (mechanical valve, bioprosthetic valve, transcatheter aortic valve replacement) and repair devices (surgical valve, transcatheter mitral valve replacement, balloon valvuloplasty devices). Replacement devices are expected to witness substantial growth, primarily due to the rapid adoption of TAVR and rising prevalence of aortic valve disorders.
Minimally Invasive Surgeries to Dominate Procedure Segment
The market share by procedure includes open surgeries and minimally invasive surgeries (MIS). Minimally invasive surgery is projected to lead the segment, supported by technological advancements, faster recovery times, reduced complications, and increasing patient demand. Together, these advantages contribute to its expanding adoption in both replacement and repair interventions.
Hospitals to Lead the End User Segmentation in the Europe Heart Valve Devices Market
Hospitals, ambulatory surgical centers (ASCs), and others together make up the end-user segmentation. Hospitals are expected to hold the largest share due to their comprehensive care capabilities, access to advanced technologies, and availability of specialized cardiac teams. Together, these factors ensure hospitals remain the primary centers for heart valve procedures.
Europe Heart Valve Devices Market Analysis by Region
The market is divided into regions such as the United Kingdom, Germany, France, Italy, and others. The United Kingdom is likely to dominate the market, driven by advanced healthcare infrastructure, rising cardiovascular disease incidence, and increasing adoption of transcatheter procedures. Germany holds a significant share due to its strong medical technology sector, while the France benefit from government support and growing demand for minimally invasive treatments.
Leading Players in the Europe Heart Valve Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Medtronic plc, established in 1949 and headquartered in the United States, is a global leader in healthcare technology with a strong presence in the European heart valve devices market. In October 2024, the company launched the Avalus Ultra Bioprosthesis valve in Western Europe. This next-generation surgical aortic valve, designed for enhanced durability and ease of implantation, builds on a decade of clinical success with the Avalus valve. Medtronic's expanding cardiac surgery portfolio highlights its commitment to advancing cardiovascular care across the region.
Edwards Lifesciences Corporation
Headquartered in Irvine, California, and established in 1958, Edwards Lifesciences Corporation is a leading innovator in structural heart therapies. In May 2024, the company expanded its presence in the Europe heart valve devices market by launching the Sapien 3 Ultra Resilia valve, a transcatheter aortic valve featuring Resilia tissue technology that enhances durability and reduces calcification. With CE Mark approval, this advanced device addresses native aortic stenosis and failed bioprosthetic valves across all surgical risk levels. Edwards' strategic focus on innovation and patient-centric care reinforces its strong market position and supports growing demand for minimally invasive valve replacement options in Europe.
Abbott
Abbott is a leader in innovative healthcare solutions, including cardiovascular devices. It is headquartered in Illinois, United States and was established in 1888. Abbott's TriClip transcatheter edge-to-edge repair (TEER) system, approved by the FDA in April 2024, is designed for treating tricuspid regurgitation. This minimally invasive device has shown positive results in improving patients' quality of life and reducing symptoms. Abbott's commitment to advancing structural heart therapies, including the MitraClip and Navitor systems, reinforces its strong position in the European heart valve devices market.
Boston Scientific Corporation
Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific Corporation is a leading global medical technology company. In August 2024, it received CE mark approval for its Acurate Prime aortic valve system, an advanced transcatheter aortic valve replacement (TAVR) device designed for patients with severe aortic stenosis. This next-generation valve expands treatment options for larger anatomies and enhances procedural accuracy through a redesigned deployment system.
Other key players in the market include Corcym Group, B. Braun SE, Getinge AB, Shockwave Medical Inc. (Johnson & Johnson, Services Inc.), JenaValve Technology, Inc., and Xeltis.
Key Questions Answered in the Europe Heart Valve Devices Market Report
- What was the Europe heart valve devices market value in 2024?
- What is the Europe heart valve devices market forecast outlook for 2025-2034?
- What is the market segmentation based on valve type?
- What is the market breakup based on the product type?
- How is the market segmented based on procedure?
- How is the market divided based on the end user?
- What major factors aid the Europe heart valve devices market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Europe Heart Valve Devices market trends?
- Which valve type is expected to dominate the market segment?
- Which product type is projected to lead the market segment?
- Which procedure is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players in the Europe heart valve devices market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Heart Valve Devices Market Overview
3.1 Global Heart Valve Devices Market Overview
3.1.1 Global Heart Valve Devices Market Historical Value (2018-2024)
3.1.2 Global Heart Valve Devices Market Forecast Value (2025-2034)
3.2 Europe Heart Valve Devices Market Overview
3.2.1 Europe Heart Valve Devices Market Historical Value (2018-2024)
3.2.2 Europe Heart Valve Devices Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Europe Heart Valve Devices Market Landscape*
5.1 Europe Heart Valve Devices Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Europe Heart Valve Devices Market: Product Landscape
5.2.1 Analysis By Valve Type
5.2.2 Analysis By Product Type
5.2.3 Analysis By Procedure
6 Europe Heart Valve Devices Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Europe Heart Valve Devices Market (218-2034)
7.1 Europe Heart Valve Devices Market (2018-2034) by Valve Type
7.1.1 Market Overview
7.1.2 Biological (Tissue) Valve
7.1.3 Mechanical Valve
7.2 Europe Heart Valve Devices Market (2018-2034) by Product Type
7.2.1 Market Overview
7.2.2 Replacement Devices
7.2.2.1 Mechanical Valve
7.2.2.2 Bioprosthetic Valve
7.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
7.2.3 Repair Devices
7.2.3.1 Surgical Valve
7.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
7.2.3.3 Balloon Valvuloplasty Devices
7.3 Europe Heart Valve Devices Market (2018-2034) by Procedure
7.3.1 Market Overview
7.3.2 Open Surgery
7.3.3 Minimally Invasive Surgery (MIS)
7.4 Europe Heart Valve Devices Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Ambulatory Surgical Centers (ASCs)
7.4.4 Others
7.5 Europe Heart Valve Devices Market (2018-2034) by Country
7.5.1 United Kingdom
7.5.2 Germany
7.5.3 France
7.5.4 Italy
7.5.5 Spain
7.5.6 Others
8 United Kingdom Heart Valve Devices Market (218-2034)
8.1 United Kingdom Heart Valve Devices Market (2018-2034) by Valve Type
8.1.1 Market Overview
8.1.2 Biological (Tissue) Valve
8.1.3 Mechanical Valve
8.2 United Kingdom Heart Valve Devices Market (2018-2034) by Product Type
8.2.1 Market Overview
8.2.2 Replacement Devices
8.2.2.1 Mechanical Valve
8.2.2.2 Bioprosthetic Valve
8.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
8.2.3 Repair Devices
8.2.3.1 Surgical Valve
8.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
8.2.3.3 Balloon Valvuloplasty Devices
8.3 United Kingdom Heart Valve Devices Market (2018-2034) by Procedure
8.3.1 Market Overview
8.3.2 Open Surgery
8.3.3 Minimally Invasive Surgery (MIS)
8.4 United Kingdom Heart Valve Devices Market (2018-2034) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Ambulatory Surgical Centers (ASCs)
8.4.4 Others
9 Germany Heart Valve Devices Market (218-2034)
9.1 Germany Heart Valve Devices Market (2018-2034) by Valve Type
9.1.1 Market Overview
9.1.2 Biological (Tissue) Valve
9.1.3 Mechanical Valve
9.2 Germany Heart Valve Devices Market (2018-2034) by Product Type
9.2.1 Market Overview
9.2.2 Replacement Devices
9.2.2.1 Mechanical Valve
9.2.2.2 Bioprosthetic Valve
9.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
9.2.3 Repair Devices
9.2.3.1 Surgical Valve
9.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
9.2.3.3 Balloon Valvuloplasty Devices
9.3 Germany Heart Valve Devices Market (2018-2034) by Procedure
9.3.1 Market Overview
9.3.2 Open Surgery
9.3.3 Minimally Invasive Surgery (MIS)
9.4 Germany Heart Valve Devices Market (2018-2034) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Ambulatory Surgical Centers (ASCs)
9.4.4 Others
10 France Heart Valve Devices Market (218-2034)
10.1 France Heart Valve Devices Market (2018-2034) by Valve Type
10.1.1 Market Overview
10.1.2 Biological (Tissue) Valve
10.1.3 Mechanical Valve
10.2 France Heart Valve Devices Market (2018-2034) by Product Type
10.2.1 Market Overview
10.2.2 Replacement Devices
10.2.2.1 Mechanical Valve
10.2.2.2 Bioprosthetic Valve
10.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
10.2.3 Repair Devices
10.2.3.1 Surgical Valve
10.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
10.2.3.3 Balloon Valvuloplasty Devices
10.3 France Heart Valve Devices Market (2018-2034) by Procedure
10.3.1 Market Overview
10.3.2 Open Surgery
10.3.3 Minimally Invasive Surgery (MIS)
10.4 France Heart Valve Devices Market (2018-2034) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Ambulatory Surgical Centers (ASCs)
10.4.4 Others
11 Italy Heart Valve Devices Market (218-2034)
11.1 Italy Heart Valve Devices Market (2018-2034) by Valve Type
11.1.1 Market Overview
11.1.2 Biological (Tissue) Valve
11.1.3 Mechanical Valve
11.2 Italy Heart Valve Devices Market (2018-2034) by Product Type
11.2.1 Market Overview
11.2.2 Replacement Devices
11.2.2.1 Mechanical Valve
11.2.2.2 Bioprosthetic Valve
11.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
11.2.3 Repair Devices
11.2.3.1 Surgical Valve
11.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
11.2.3.3 Balloon Valvuloplasty Devices
11.3 Italy Heart Valve Devices Market (2018-2034) by Procedure
11.3.1 Market Overview
11.3.2 Open Surgery
11.3.3 Minimally Invasive Surgery (MIS)
11.4 Italy Heart Valve Devices Market (2018-2034) by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Ambulatory Surgical Centers (ASCs)
11.4.4 Others
12 Spain Heart Valve Devices Market (218-2034)
12.1 Spain Heart Valve Devices Market (2018-2034) by Valve Type
12.1.1 Market Overview
12.1.2 Biological (Tissue) Valve
12.1.3 Mechanical Valve
12.2 Spain Heart Valve Devices Market (2018-2034) by Product Type
12.2.1 Market Overview
12.2.2 Replacement Devices
12.2.2.1 Mechanical Valve
12.2.2.2 Bioprosthetic Valve
12.2.2.3 Transcatheter Aortic Valve Replacement (TAVR)
12.2.3 Repair Devices
12.2.3.1 Surgical Valve
12.2.3.2 Transcatheter Mitral Valve Replacement (TMVR)
12.2.3.3 Balloon Valvuloplasty Devices
12.3 Spain Heart Valve Devices Market (2018-2034) by Procedure
12.3.1 Market Overview
12.3.2 Open Surgery
12.3.3 Minimally Invasive Surgery (MIS)
12.4 Spain Heart Valve Devices Market (2018-2034) by End User
12.4.1 Market Overview
12.4.2 Hospitals
12.4.3 Ambulatory Surgical Centers (ASCs)
12.4.4 Others
13 Patent Analysis
13.1 Analysis By Drug Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Drug Class of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Drug Class of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Europe
17.1.2 Market Share Analysis: Asia Pacific
17.1.3 Market Share Analysis: Others
17.2 Medtronic plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 Edwards Lifesciences Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 Abbott
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Corcym Group
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Boston Scientific Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 B. Braun SE
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Getinge AB
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Shockwave Medical Inc. (Johnson & Johnson, Services Inc.)
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 JenaValve Technology, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Xeltis
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
18 Europe Heart Valve Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security